|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/64 | |
| C07K 1/22 |
| (11) | Number of the document | 3472314 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17814267.5 |
| Date of filing the European patent application | 2017-06-19 | |
| (97) | Date of publication of the European application | 2019-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/038169 |
| Date | 2017-06-19 |
| (87) | Number | WO 2017/219034 |
| Date | 2017-12-21 |
| (30) | Number | Date | Country code |
| 201662351841 P | 2016-06-17 | US |
| (72) |
KARBARZ, Mark, US
CONLEY, Pamela B., US
LU, Genmin, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | PREPARATION OF FACTOR XA DERIVATIVES |
| PREPARATION OF FACTOR XA DERIVATIVES |